B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study | Zendy

Katharina Spanaus | Zendy; Florian Kronenberg | Zendy; Eberhard Ritz | Zendy; Ralph Schlapbach | Zendy; Danilo Fliser | Zendy; Martin Hersberger | Zendy; Barbara Kollerits | Zendy; Paul König | Zendy; Arnold von Eckardstein | Zendy

Open Access

B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study

Author(s) -

Katharina Spanaus,

Florian Kronenberg,

Eberhard Ritz,

Ralph Schlapbach,

Danilo Fliser,

Martin Hersberger,

Barbara Kollerits,

Paul König,

Arnold von Eckardstein

Publication year - 2007

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2006.083170

Subject(s) - natriuretic peptide , medicine , kidney disease , heart failure , kidney , clinical significance , disease , cardiology , endocrinology

Plasma concentrations of B-type natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are diagnostic and prognostic biomarkers of heart failure and are also increased in patients with chronic kidney disease (CKD). We examined the relevance of BNP and NT-proBNP as predictors of CKD progression.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research